Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation

BACKGROUND: Rituximab, an anti-CD20 antibody, effectively depletes B lymphocytes. It is not clear whether the use of conventional doses of mycophenolate mofetil (MMF), methylprednisolone and tacrolimus as maintenance immunosuppression in rituximab-treated kidney transplantation is associated with in...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Chung Hee, Yang, Won Seok, Park, Kyung Sun, Han, Duck Jong, Park, Jae Berm, Park, Su-Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350352/
https://www.ncbi.nlm.nih.gov/pubmed/22619669
http://dx.doi.org/10.1159/000337339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350352/
https://www.ncbi.nlm.nih.gov/pubmed/22619669
http://dx.doi.org/10.1159/000337339

Ejemplares similares